Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
filingDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962730b64b9af53edf3067be9d0cf8e3 |
publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004229933-A1 |
titleOfInvention |
Treatment of hypertension |
abstract |
The present invention relates to the use of a modulator of the Kiss-1 receptor for the treatment of blood pressure disorders, in particular to the use of a Kiss-1 receptor antagonist for the treatment of hypertension. The invention also provides methods of screening for compounds useful in the treatment of hypertension. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011046068-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916681-B2 |
priorityDate |
2003-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |